Overview

A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects

Status:
Recruiting
Trial end date:
2024-10-16
Target enrollment:
Participant gender:
Summary
This is a study of HS-20094 in participants with overweight and obesity. The main purpose is to learn more about how HS-20094 affects body weight. The study period including 4-12 weeks dose titration and 12-20 weeks maintain treatment and 6 weeks follow up.
Phase:
Phase 2
Details
Lead Sponsor:
Jiangsu Hansoh Pharmaceutical Co., Ltd.